Edgewise Therapeutics
Janet Hill started their work experience as an Accountant at Sugarloaf in November 2002. Janet then moved on to become a Senior Accountant at Westwood College in August 2003, and later at Intrado in November 2004. In August 2012, they joined Clovis Oncology as a Financial Accountant and eventually became the Manager of Financial Analysis in March 2021. Currently, they are a Senior Analyst at Edgewise Therapeutics since December 2022.
Janet Hill attended Canisius College from 1996 to 2000, where they pursued a Bachelor of Science (BS) degree with a major in Accounting.
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.